Tumor Metabolism 2025
This collection emphasizes the pivotal role of tumor metabolism in cancer progression, immune modulation, and therapy resistance. It highlights cutting-edge research on metabolic vulnerabilities, including the impact of hypoxia on immune checkpoint resistance and metabolic shifts that drive chemoresistance. The collection also explores how immune cells, metabolic pathways, and epigenetic regulation contribute to tumor survival and adaptation. By unraveling these complex metabolic networks, the articles offer valuable insights into novel therapeutic targets and strategies aimed at overcoming the metabolic challenges that tumors present.
We hope you enjoy reading this collection, and we invite you to follow JEM on Bluesky (@jem.org) or X/Twitter (@JExpMed). To learn more about JEM or to submit your research, please visit our Instructions for Authors or reach out to our team of editors. Sign up to receive future special collections here.
Image © 2024 Folkert et al.
